Ameriprise Financial Increases Stake in Zimmer Biomet

Institutional investor grows position in medical device company by 1.6% in Q3

Mar. 17, 2026 at 7:08am

Got story updates? Submit your updates here. ›

Ameriprise Financial Inc. increased its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.6% in the third quarter, according to a recent SEC filing. The fund now owns 3,789,200 shares of the medical equipment provider's stock, valued at $373,239,000, representing a 1.91% ownership stake.

Why it matters

Zimmer Biomet is a leading global medical device company focused on musculoskeletal healthcare products. Institutional investor activity in the company's stock can provide insight into market sentiment and future performance expectations.

The details

Ameriprise Financial acquired an additional 58,335 shares of Zimmer Biomet during the third quarter, bringing its total position to 3,789,200 shares. This represents a 1.6% increase in the fund's holdings compared to the prior quarter. Ameriprise Financial is now the beneficial owner of 1.91% of Zimmer Biomet's outstanding shares.

  • Ameriprise Financial increased its Zimmer Biomet holdings in the third quarter of 2026.

The players

Ameriprise Financial Inc.

A diversified financial services firm that provides wealth management, asset management, insurance, annuities, and other financial products and services.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, designing, manufacturing, and marketing a broad portfolio of products used to treat joint disorders, bone disorders, and related conditions.

Got photos? Submit your photos here. ›

The takeaway

Ameriprise Financial's increased stake in Zimmer Biomet suggests the institutional investor sees growth potential in the medical device company, which could signal broader market optimism about Zimmer Biomet's future performance.